EP1692176A4 - Anti-igf-i-rezeptor-antikörper - Google Patents
Anti-igf-i-rezeptor-antikörperInfo
- Publication number
- EP1692176A4 EP1692176A4 EP04811082A EP04811082A EP1692176A4 EP 1692176 A4 EP1692176 A4 EP 1692176A4 EP 04811082 A EP04811082 A EP 04811082A EP 04811082 A EP04811082 A EP 04811082A EP 1692176 A4 EP1692176 A4 EP 1692176A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- igf
- receptor antibody
- antibody
- receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/729,441 US8034904B2 (en) | 2002-06-14 | 2003-12-08 | Anti-IGF-I receptor antibody |
PCT/US2004/038230 WO2005061541A1 (en) | 2002-06-14 | 2004-12-07 | Anti-igf-i receptor antibody |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1692176A1 EP1692176A1 (de) | 2006-08-23 |
EP1692176A4 true EP1692176A4 (de) | 2008-11-12 |
Family
ID=36616549
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP04811082A Ceased EP1692176A4 (de) | 2003-12-08 | 2004-12-07 | Anti-igf-i-rezeptor-antikörper |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1692176A4 (de) |
JP (1) | JP2008502589A (de) |
KR (1) | KR20070001883A (de) |
CN (1) | CN1886424A (de) |
AU (1) | AU2004303792A1 (de) |
BR (1) | BRPI0417406A (de) |
CA (1) | CA2548065A1 (de) |
CR (1) | CR8426A (de) |
EA (1) | EA009807B1 (de) |
EC (1) | ECSP066595A (de) |
IL (1) | IL174770A0 (de) |
MX (1) | MXPA06005540A (de) |
NO (1) | NO20063155L (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG181834A1 (en) | 2009-12-21 | 2012-07-30 | Genentech Inc | Antibody formulation |
NZ603972A (en) * | 2010-05-11 | 2014-11-28 | Aveo Pharmaceuticals Inc | Anti-fgfr2 antibodies |
EP2766478A4 (de) | 2011-10-10 | 2015-06-17 | Los Angeles Childrens Hospital | Neue asparaginase und verfahren zur behandlung von erkrankungen im zusammenhang mit asparaginabhängigkeit |
CN103509117B (zh) * | 2013-05-06 | 2016-03-09 | 江苏匡亚生物医药科技有限公司 | 抗人her2和人igf-ir的双特异性抗体及其制备方法和用途 |
CA3056573A1 (en) * | 2017-05-30 | 2018-12-06 | Teijin Pharma Limited | Anti-igf-i receptor antibody |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002053596A2 (en) * | 2001-01-05 | 2002-07-11 | Pfizer Inc. | Antibodies to insulin-like growth factor i receptor |
WO2003106621A2 (en) * | 2002-06-14 | 2003-12-24 | Immunogen, Inc. | Anti-igf-i receptor antibody |
WO2004071529A2 (en) * | 2003-02-13 | 2004-08-26 | Pfizer Products Inc. | Uses of anti-insulin-like growth factor i receptor antibodies |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL143514A0 (en) * | 1998-12-04 | 2002-04-21 | Novartis Ag | METHODS AND COMPOSITIONS USEFUL FOR TARGETING ACTIVATED VITRONECTIN RECEPTOR αvβ3 |
-
2004
- 2004-12-07 MX MXPA06005540A patent/MXPA06005540A/es active IP Right Grant
- 2004-12-07 CN CNA200480034889XA patent/CN1886424A/zh active Pending
- 2004-12-07 EA EA200600931A patent/EA009807B1/ru not_active IP Right Cessation
- 2004-12-07 JP JP2006543832A patent/JP2008502589A/ja active Pending
- 2004-12-07 AU AU2004303792A patent/AU2004303792A1/en not_active Abandoned
- 2004-12-07 EP EP04811082A patent/EP1692176A4/de not_active Ceased
- 2004-12-07 KR KR1020067010010A patent/KR20070001883A/ko not_active Application Discontinuation
- 2004-12-07 CA CA002548065A patent/CA2548065A1/en not_active Abandoned
- 2004-12-07 BR BRPI0417406-2A patent/BRPI0417406A/pt not_active IP Right Cessation
-
2006
- 2006-04-04 IL IL174770A patent/IL174770A0/en unknown
- 2006-05-31 EC EC2006006595A patent/ECSP066595A/es unknown
- 2006-06-01 CR CR8426A patent/CR8426A/es not_active Application Discontinuation
- 2006-07-07 NO NO20063155A patent/NO20063155L/no not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002053596A2 (en) * | 2001-01-05 | 2002-07-11 | Pfizer Inc. | Antibodies to insulin-like growth factor i receptor |
WO2003106621A2 (en) * | 2002-06-14 | 2003-12-24 | Immunogen, Inc. | Anti-igf-i receptor antibody |
WO2004071529A2 (en) * | 2003-02-13 | 2004-08-26 | Pfizer Products Inc. | Uses of anti-insulin-like growth factor i receptor antibodies |
Non-Patent Citations (3)
Title |
---|
RUDIKOFF S ET AL: "Single amino acid substitution altering antigen-binding specificity", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC; US, vol. 79, 1 March 1982 (1982-03-01), pages 1979 - 1983, XP007901436, ISSN: 0027-8424, DOI: 10.1073/PNAS.79.6.1979 * |
See also references of WO2005061541A1 * |
SURMACZ E: "Growth factor receptors as therapeutic targets: Strategies to inhibit the insulin-like growth factor I receptor", ONCOGENE, NATURE PUBLISHING GROUP, GB BASINGSTOKE, HANTS, vol. 22, no. 42, 29 September 2003 (2003-09-29), pages 6589 - 6597, XP002392351, ISSN: 0950-9232 * |
Also Published As
Publication number | Publication date |
---|---|
AU2004303792A1 (en) | 2005-07-07 |
ECSP066595A (es) | 2006-10-17 |
MXPA06005540A (es) | 2006-08-17 |
JP2008502589A (ja) | 2008-01-31 |
CN1886424A (zh) | 2006-12-27 |
EA009807B1 (ru) | 2008-04-28 |
IL174770A0 (en) | 2006-08-20 |
BRPI0417406A (pt) | 2007-04-03 |
CA2548065A1 (en) | 2005-07-07 |
EA200600931A1 (ru) | 2006-10-27 |
NO20063155L (no) | 2006-08-11 |
EP1692176A1 (de) | 2006-08-23 |
KR20070001883A (ko) | 2007-01-04 |
CR8426A (es) | 2007-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL175710A0 (en) | Anti-mpl antibody | |
IL175608A0 (en) | Antibodies | |
PT1599504E (pt) | Anticorpo modificado | |
EP1494693A4 (de) | Criptospezifische antikörper | |
IL181575A0 (en) | Anti-ox40l antibodies | |
IL228032A0 (en) | Antibodies | |
PL375405A1 (en) | Antibodies | |
IL172822A0 (en) | Muscarnic acetylcholine receptor antagonists | |
GB0420466D0 (en) | Anti-glucan antibodies | |
AU2003257032A8 (en) | Antibodies against c3a receptor | |
ZA200701952B (en) | Anti-OX40L antibodies | |
IL173337A0 (en) | Receptor | |
IL163580A0 (en) | Assay for anti-ingap antibodies | |
EP1692176A4 (de) | Anti-igf-i-rezeptor-antikörper | |
EP1696949A4 (de) | Vegf-rezeptor-antagonisten | |
EP1780221A4 (de) | Anti-synoviolin-antikörper | |
GB0306618D0 (en) | Antibody | |
GB0306428D0 (en) | Receptor proteins | |
GB0215389D0 (en) | Receptor | |
GB0226878D0 (en) | Antibodies | |
GB0321998D0 (en) | Receptor | |
GB0418415D0 (en) | Antibody | |
HK1209139A1 (en) | Modified antibody | |
GB0307100D0 (en) | Receptor | |
GB0329104D0 (en) | Receptor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20060612 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: BA HR LV MK YU |
|
RAX | Requested extension states of the european patent have changed |
Extension state: YU Payment date: 20060612 Extension state: MK Payment date: 20060612 Extension state: LV Payment date: 20060612 Extension state: HR Payment date: 20060612 Extension state: BA Payment date: 20060612 Extension state: AL Payment date: 20060612 |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20081010 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 39/395 20060101ALI20081006BHEP Ipc: C07K 16/28 20060101ALI20081006BHEP Ipc: C12N 15/00 20060101ALI20081006BHEP Ipc: C07H 21/04 20060101ALI20081006BHEP Ipc: C07K 16/00 20060101AFI20050708BHEP |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: IMMUNOGEN, INC. |
|
17Q | First examination report despatched |
Effective date: 20100211 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R003 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
18R | Application refused |
Effective date: 20120719 |